ArticleBlood2025

Outcomes of allogeneic HCT in Hodgkin lymphoma in the era of checkpoint inhibitors: a joint CIBMTR and EBMT analysis.

Miguel-Angel Perales et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.